EQT in advanced talks to acquire Qiagen for over $10bn
EQT is in advanced negotiations to acquire European molecular testing company Qiagen in a potential buyout valued at more than $10bn, with rival private equity firm KKR also submitting a bid, according to a report by Bloomberg.

